" /> Leukemia, chronic lymphocytic, susceptibility to, 2 - CISMeF





Preferred Label : Leukemia, chronic lymphocytic, susceptibility to, 2;

CISMeF acronym : BCLL; CLLS2; DBM;

Type : Phenotype or locus, molecular basis unknown;

Alternative titles and symbols : CLLS2; Disrupted in b-cell malignancy; DBM; B-cell malignancy, low-grade; BCLL; Leukemia, chronic lymphocytic, b-cell;

Description : For a phenotypic description and a discussion of genetic heterogeneity of chronic lymphocytic leukemia (CLL), see 151400.;

Inheritance : Autosomal dominant (13q14);

Prefixed ID : %109543;

Détails


Vous pouvez consulter :


Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.